Recent-Onset Type 1 Diabetes Extension Study Evaluating the Long-Term Safety of Teplizumab (PROTECT Extension)

Clinical trial NCT04598893 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04598893
Sponsor: Provention Bio, a Sanofi Company
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Diabetes Mellitus, Type 1

Start date: 2020-10-26
Primary completion: 2026-11-01
Enrollment: 188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.